Abstract

Leptospirosis is a zoonotic disease of global importance. The breadth of Leptospira diversity associated with both human and animal disease poses major logistical challenges to the use of classical diagnostic techniques, and increasingly molecular diagnostic tools are used for their detection. In New Zealand, this has resulted in an increase in positive cases reported nationally that have not been attributed to the infecting serovar or genomospecies. In this study, we used data from all pathogenic Leptospira genomes to identify a partial region of the glmU gene as a suitable locus for the discrimination of the infecting species and serovars of New Zealand-endemic Leptospira. This method can be used in culture and culture-independent scenarios making it flexible for diagnostics in humans, animals, and environmental samples. We explored the use of this locus as a molecular barcoding tool via the Oxford Nanopore Technology (ONT) sequencing platform MinION. Sequences obtained by this method allowed specific identification of Leptospira species in mixed and enriched environmental cultures, however read error inherent in the MinION sequencing system reduced the accuracy of strain/variant identification. Using this approach to characterise Leptospira in enriched environmental cultures, we detected the likely presence of Leptospira genomospecies that have not been reported in New Zealand to date. This included a strain of L. borgpetersenii that has recently been identified in dairy cattle and sequences similar to those of L. mayottensis. L. tipperaryensis, L. dzianensis and L. alstonii.

Highlights

  • Leptospirosis is a neglected zoonotic disease with a worldwide distribution [1]

  • Our results suggest that the full diversity of pathogenic Leptospira circulating in New Zealand is yet to be fully described and that further work will be needed to assess the risk of human infection from the newly identified Leptospira lineages

  • This study was carried out with the aim of developing a molecular method that can be used for detecting and identifying pathogenic Leptospira genomospecies and serovars circulating in New Zealand, with the potential to identify specific strains of interest in human, animal and environmental samples

Read more

Summary

Introduction

Leptospirosis is a neglected zoonotic disease with a worldwide distribution [1]. It is estimated to cause 1.03 million cases and 58.9 thousand deaths annually, the true global burden of the disease is likely under-estimated [2]. Infection commonly results in undifferentiated febrile illness, which is often misdiagnosed, diagnostic tests are difficult to perform and there are limitations with current techniques [3]. Leptospirosis is caused by bacteria of the genus Leptospira [4].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call